CONTINUING EDUCATION
Heart Failure: A Guideline Directed Medical Therapy Approach to Diagnosis and Treatment This CE activity has been produced by the Innovatix Institute, an educational program offered by Innovatix, LLC (“Innovatix”). This activity is accredited for pharmacists and pharmacy technicians.
Goal Statement
The purpose of this activity is to provide participants with the knowledge necessary to understand the:
■■ Risk factors associated with heart failure; ■■ Importance of using guideline directed medical therapy (GDMT) for the treatment of heart failure; and
■■ Selection process to determine the best agent for patients based on this guidance.
Learning Objectives – Pharmacists
At the completion of this activity, the participant will be able to: 1. Summarize the prevalence, definition, and pathophysiology of heart failure (HF). 2. Describe the comorbidities associated with HF and the importance of treating them. 3. List the clinical assessment and testing necessary to support making a diagnosis of heart failure. 4. Describe the recommendations in the ACC/AHA guideline directed medical therapy for the treatment of HF.
Learning Objectives – Pharmacy technicians
At the completion of this activity, the participant will be able to: 1. Define heart failure. 2. Identify two oral medications used to treat heart failure. 3. List two injectable medications used to manage heart failure.
Target Audience This education is designed for pharmacists and technicians involved in the management of patients with heart failure and its comorbidities.
Type of activity Knowledge-based
Cost
This activity is free of charge.
Disclosures
This continuing education activity is managed and accredited by Innovatix. Ms. Hofman and Innovatix have no relevant or apparent financial interests or relationships to disclose. The material presented for this article has been reviewed by the Innovatix Institute CE Committee and has been found to be free of any content influenced or supported by industry. Commercial support was not received for this activity.
Pharmacy Accreditation
Innovatix, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity has been approved for one contact hour for pharmacists and pharmacy technicians. Universal Activity Number: 0409-0000-18-005-H01-P (Pharmacists) and 0409-0000-18-005-H01-T (Technicians).
To receive CE credit, Pharmacists and Technicians must go to www.innovatix.com/evaluations. Click on Insight Magazine and scroll to find the title of this CE article. Complete the evaluation form. A score of 70 percent or higher is required to receive credit. Statements of Credit will be available from CPE Monitor within eight weeks of successful completion and submission of the online verification of Continuing Education and Program Evaluation forms and receipt of a passing score on the test. This lesson will not be valid for CE credit after April 1, 2020.
Legal Disclaimer The materials in this CE activity do not necessarily reflect the views of Innovatix or its affiliates. A qualified healthcare professional should be consulted before using any therapeutic product referenced as part of the program. Readers should verify all information and data before treating patients or employing any therapies described in the activity materials. As a condition to participating in this program, you acknowledge and agree that Innovatix is not providing any medical conclusions or advice, but is rather summarizing publicly available clinical information. The activity and corresponding materials may contain statements that may appear to be recommendations or advisory in nature, however, such statements are merely being recounted by Innovatix from the literature cited and do not constitute the recommendations or advice of Innovatix. Accordingly, Innovatix hereby disclaims all warranties, express or implied, as to the accuracy of any of the materials or information contained in the activity, or their fitness for any particular use or purpose. Clinical information and comments contained in the activity are for general guidance only. Mention of specific products in the activity or corresponding materials do not constitute an endorsement or advertisement. The activity provided is intended to provide you with information and is not intended to be used as a substitute for clinical or medical judgment. You agree that Innovatix shall not be responsible to you or any other third party for any clinical advice rendered by you, including advice related in any way to the activity. You agree to indemnify, defend, and hold Innovatix and its officers, directors, affiliates, employees, and agents (the “Innovatix Indemnitees”), harmless from and against any liability, costs, expenses, or damages, including attorneys’ fees and other costs of defense, incurred by any Innovatix Indemnitee in any action, proceeding, claim, or demand that is caused by, relates to, or arises out of your acts or omissions, or that in any way relate to your use of the information contained in the program or program materials. You agree that the activity and corresponding materials will be used for educational purposes only, and will not otherwise be copied or distributed without the prior written consent of Innovatix.
18 |
Insight